Abstract |
Soft, lipid-containing carotid plaques, which appear echolucent on ultrasound imaging, have been associated with increased risk of ischemic stroke. We sought to investigate the effect of short-term treatment with atorvastatin on the change of carotid plaque echodensity. We treated 40 stroke-free and statin-naive subjects with 80 mg atorvastatin daily for 30 days. Computer assisted gray-scale densitometry (GSD) index was calculated at baseline and 30 days after treatment from the normalized plaque images. A multiple logistic regression was used to assess the effect modification of low-density lipoprotein ( LDL) cholesterol on plaque stabilization after adjusting for age, sex, and smoking. The average number of carotid plaques at baseline was 2 (range: 0-5; 27 subjects with carotid plaque) and did not change 30 days following atorvastatin treatment. The mean GSD index significantly increased from 73±16 (range: 1-125) at baseline to 89±15 (range: 1-137) at 30 days after treatment (P<0.05). The adjusted odds ratio for the positive GSD plaque index change (vs. no change or decreased gray-scale median (GSM) index) was 1.71 (95% confidence interval: 1.1-7.6, P<0.01). In conclusion, we observed decreased echolucency (increased echodensity) of carotid artery plaques after short-term treatment with atorvastatin.
|
Authors | David Della-Morte, Issam Moussa, Mitchell S Elkind, Ralph L Sacco, Tatjana Rundek |
Journal | Neurological research
(Neurol Res)
Vol. 33
Issue 9
Pg. 991-4
(Nov 2011)
ISSN: 1743-1328 [Electronic] England |
PMID | 22081003
(Publication Type: Clinical Trial, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cholesterol, LDL
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Pyrroles
- Atorvastatin
|
Topics |
- Aged
- Atorvastatin
- Carotid Stenosis
(diagnostic imaging, drug therapy)
- Cholesterol, LDL
(blood)
- Densitometry
(methods)
- Female
- Heptanoic Acids
(therapeutic use)
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(therapeutic use)
- Image Interpretation, Computer-Assisted
(methods)
- Male
- Pilot Projects
- Pyrroles
(therapeutic use)
- Ultrasonography
|